Jaime Leandro Foundation for Therapeutic Cancer Vaccines

“The Jaime Leandro Foundation for Therapeutic Cancer Vaccines (JLF) is a private nonprofit organization established to deliver breakthrough cancer treatments based on the latest innovations in research and personalized medicine and leveraging the Expanded Access rule — also known as “Compassionate Use.””

“The Jaime Leandro Foundation (JLF) is a private nonprofit created to help patients access personalized neoantigen peptide vaccines via the expanded access patient pay cost recovery program. The expanded access program gives individuals the right to try a medical treatment when no comparable alternative options are available.”

“The Jaime Leandro Foundation (JLF) is a private nonprofit organization established to deliver breakthrough cancer treatments. We are a unique consortium of experts in cancer, personalized medicine, clinical trials, and vaccines leveraging the FDA’s Expanded Access rule, also known as “compassionate use,” to develop personalized cancer vaccines.”

Jaime Leandro Foundation treats first cancer patient with personalized neoantigen peptide vaccine under expanded access; First-of-its-kind consortium enables cancer patients to receive anticancer vaccine therapy through compassionate use.

The Jaime Leandro Foundation (JLF) is a private nonprofit organization established to deliver breakthrough cancer treatments. We are a unique consortium of experts in cancer, personalized medicine, clinical trials, and vaccines leveraging the FDA’s Expanded Access rule, also known as “compassionate use,” to develop personalized cancer vaccines.

The Jaime Leandro Foundation (JLF) is a private nonprofit organization established to deliver breakthrough cancer treatments. We are a unique consortium of experts in cancer, personalized medicine, clinical trials, and vaccines leveraging the FDA’s Expanded Access rule, also known as “compassionate use,” to develop personalized cancer vaccines.